Login / Signup

Tocilizumab for COVID-19: a real 'miracle drug'?

Sundus NasimShariq Haider HashmiDua AzimSohail KumarJasia Nasim
Published in: Infectious diseases (London, England) (2020)
Keyphrases
  • coronavirus disease
  • sars cov
  • rheumatoid arthritis
  • juvenile idiopathic arthritis
  • rheumatoid arthritis patients
  • respiratory syndrome coronavirus
  • adverse drug
  • emergency department